MYCN and neuroblastoma: In addition, we have identified a small molecule compound inhibitor of the PRKCQ‐AS1 RNA and MSI2 protein interaction and have confirmed its anticancer efficacy in vitro and in a mouse model of MYCN nonamplified neuroblastoma.